Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Commercial

Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool

 April 17, 2026

BioPharma Dive

Some 1,390 Foundayo prescriptions were written in two days, according to analysts.

CommercialMetabolic & GLP-1Read full story

Post navigation

Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch →
← Kailera makes history with record-breaking $625m IPO

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com